Industry Notes / Pharma / Chapter 4 of 20 · Bar
The same category can still split apart
A right market and weak execution can still fall
Eli Lilly
1120 $bn
Novo Nordisk
160 $bn
In August 2026 Eli Lilly was about $1.12 trillion and Novo Nordisk about $160 billion. They were close three years earlier. Novo did not lose because GLP-1 was the wrong category.
Source:YCharts / TradingEconomics 市值(2026-08);经营指引以礼来、诺和诺德公司公告为准
Research notes, not investment advice.